PMID: 17315030 Clemmons DR
Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents McCoy AT, Benoist CC, Wright JW, et al
Recalls & Warnings June 11, 2015 FDA Warns Maker of Fruit Energy Drinks for Drug Claims On May 19, 2015, the FDA issued a warning letter to CK Management, Inc
S.MonksT
Scenario 1: Pre-conception Planning 28-year-old woman, BMI 26 kg/m2with T2DM on Metformin and liraglutide, planning pregnancy
Prescription GLP-1 receptor agonists may be indicated for adults with type 2 diabetes not meeting glycemic targets, those with established cardiovascular disease or chronic kidney disease, or individuals with obesity and weight-related complications when lifestyle interventions prove insufficient